Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,850 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04617717Recruiting
Personalized treatment for abnormal heartbeats needing ablation
This trial studies a customized treatment plan for people who have premature ventricular beats (PVCs) and have been referred for a procedure called PVC ablation. It may help doctors choose the best approach for stopping these extra heartbeats.
OsloAges 18–90 - NCT04623502Recruiting
Study of kidney and bladder cancer metabolism during surgery
This study looks at how kidney and bladder (urothelial) tumors use fuel by taking samples during surgery or biopsy. It may help researchers learn what drives these cancers and guide better future treatments.
Dallas, TexasAges 18 years+ - NCT04625556Recruiting
Urology cancer registry study using body microbiome data
This study builds a patient registry for prostate, kidney, bladder, and ureter cancers by analyzing your body’s microbiome (the microbes living in/ on the body). It may help doctors personalize care in the future, and your participation mainly involves allowing your medical and related information to be used for research.
SeoulAges 20 years+ - NCT04626440Recruiting
Testing DNA/RNA tools to study different breast cancer types
This study uses special DNA and RNA testing tools to better understand differences between breast cancer tumors in Taiwanese patients. It may help doctors choose more personalized treatment approaches by learning how tumors vary.
TaipeiAges 20 years+ - NCT04628026RecruitingPhase 3
Venetoclax plus chemotherapy for new AML or high-risk MDS
This trial tests adding venetoclax to standard chemotherapy to help people with newly diagnosed acute myeloid leukemia (AML) or high-risk MDS (MDS-EB-2) live longer and reduce cancer activity. You may benefit if you’re eligible for intensive chemotherapy and meet specific blood, organ, and treatment timing requirements.
InnsbruckAges 18–75 - NCT04629352Recruiting
tDCS brain-stimulation for hearing voices in schizophrenia
This study tests whether a non-invasive brain-stimulation treatment (tDCS) can improve response to care in people who experience clinically significant hearing voices. It may help by changing brain activity, aiming to reduce or improve auditory hallucinations.
Bengaluru, KarnatakaAges 18–45 - NCT04634240Recruiting
Staged heart bypass plus TAVR versus TAVR alone
This study compares doing a staged coronary bypass (revascularization) along with a valve procedure (TAVR) versus doing TAVR and medical treatment alone. It aims to see which approach better helps people with both aortic valve narrowing and coronary artery disease.
Huntsville, AlabamaAges Any age - NCT04636879Recruiting
Testing dry needling for neck pain expectations
This study looks at how people’s expectations and experiences relate to treatment with dry needling for neck pain. It may help researchers understand who benefits most from this therapy for upper trapezius muscle pain.
Alcalá de Henares, MadridAges 18–65 - NCT04639791Recruiting
Managing asthma in adults on GINA steps 4 to 5
This study looks at how well guideline-based asthma treatment works for adults with more severe asthma (GINA steps 4 and 5). It may help improve real-world care for people whose asthma needs stronger medications to stay controlled.
ShatinAges 18 years+ - NCT04641416Recruiting
Ultrasound test for people with HeartMate 3 blood pumps
This study checks whether a noninvasive ultrasound-based method can help diagnose what’s going on in people with a HeartMate 3 blood pump. It may help detect important pump-related changes while keeping the process safer for certain high-risk situations.
ViennaAges 18–75 - NCT04641936Recruiting
Urine tests to predict response to immunotherapy in bladder cancer
This study uses urine “omics” tests (detailed lab patterns from urine) to predict whether immunotherapy will work for people with metastatic urothelial (bladder/urinary tract) cancer. It may help doctors choose the right treatment sooner by identifying who is more likely to benefit.
TaipeiAges 20 years+ - NCT04642430RecruitingPhase 4
Test of blood thinners comparing rivaroxaban vs apixaban
This trial compares the bleeding risk of two commonly used blood thinners—rivaroxaban and apixaban—in people with atrial fibrillation (AF). If you’re starting an anticoagulant for a new AF diagnosis, this may help doctors choose the safer option for you and others.
Victoria, British ColumbiaAges 18 years+ - NCT04644042Recruiting
Surgery for shoulder pain after non-surgical treatment fails
This trial looks at whether arthroscopic subacromial decompression surgery helps people whose “impingement” shoulder pain hasn’t improved after supervised exercises and an injection. It may help if your symptoms match their specific non-responder pattern and you can complete rehab visits.
Hvidovre, DenmarkAges 18–99 - NCT04645628Recruiting
Improving MRI scan order for better comfort and image quality
This study looks at the best order to take MRI images so scans are more comfortable and produce better-quality pictures. You may be eligible if you are having an MRI of many body areas as part of your routine care.
NancyAges 18 years+ - NCT04647331Recruiting
Study antibiotic levels in heart valve infection
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
GothenburgAges 18 years+ - NCT04650243RecruitingPhase 4
Testing whether lowering UDCA helps people with PBC
This trial looks at whether slowly reducing UDCA (a medication for primary biliary cholangitis) is safe and still helpful in people whose liver tests have improved. It may help some patients avoid higher doses if their disease is well controlled.
BeijingAges 18 years+ - NCT04653012Recruiting
Testing brain-activity recordings in people with drug-resistant epilepsy
This study looks at brain activity using electrodes placed inside the brain in people with focal, drug-resistant epilepsy before surgery. It may help doctors better map where seizures start and improve planning for treatment.
ParisAges 18 years+ - NCT04656184RecruitingPhase 3
Anakinra vs IVIG for kids who don’t respond to first IVIG
This study compares two treatments—anakinra and IVIG—for children with Kawasaki disease who still have fever after their first standard IVIG treatment. It aims to find which option works better and is safer for “IVIG non-responders” who may be at risk for heart complications.
Le Kremlin-Bicêtre, Val De MarneAges 3 months–17 years - NCT04654650Recruiting
Study of adults with pulmonary hypertension for long-term data
This study follows adults with pulmonary hypertension over the long term and collects information (and possibly samples) to better understand how the condition changes over time. It may help researchers learn what factors affect outcomes, which can improve care in the future.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT04655066Recruiting
Questionnaire study for pelvic floor symptoms during cancer treatment
This study asks people with breast or gynecologic cancer who are receiving cancer treatment to complete a validated questionnaire about how their pelvic floor feels. The goal is to better understand pelvic floor function and symptoms during systemic (whole-body) cancer therapy, which may help future care.
WiesbadenAges 18 years+ - NCT04657861RecruitingEarly Phase 1
BCMA/TACI CAR-T for relapsed or refractory multiple myeloma
This early-phase study tests a CAR-T cell treatment made to target BCMA and TACI proteins in multiple myeloma. It may help people whose myeloma has come back or did not respond to prior treatments, especially after certain prior therapies.
Hangzhou, ZhejiangAges 18–75 - NCT04657783Recruiting
French cohort study of people with type 1 diabetes
This study follows people with type 1 diabetes in France to better understand the condition over time. It may help researchers improve future care, especially for how type 1 diabetes starts and is managed from early diagnosis onward.
ParisAges 6–100 - NCT04657822RecruitingPhase 4
Crizanlizumab rollover study for people with sickle cell disease
This study lets people with sickle cell disease who already finished a Novartis crizanlizumab trial continue treatment under a rollover plan. It’s designed for participants who benefited from crizanlizumab and completed the earlier study schedule without major ongoing side effects.
Birmingham, AlabamaAges 6 months–100 years - NCT04659291Recruiting
Studying people in Hong Kong who may have sleep apnea
This study looks at people who may have obstructive sleep apnea, a breathing problem during sleep. It aims to better understand the condition in Hong Kong and what to do next for diagnosis or care.
Hong Kong, Please SelectAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,850 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.